This article is more than 5 years old. Information may no longer be current.

Glaukos receives patent for shunts, surgical methods

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The United States Patent and Trademark Office has issued a patent to Glaukos for shunt devices to treat glaucoma and the method of implanting those devices, according to a company press release.

The patent, titled “Shunt Device and Method for Treating Ocular Disorders,” covers both ocular devices and methods of surgically implanting those devices within Schlemm’s canal to facilitate aqueous humor flow, the release said.

“This issued patent strengthens the protection of our inventions, further substantiates the proprietary nature of our technology and further expands our portfolio of more than 200 patents issued in the U.S. and major international markets,” Thomas Burns, president and CEO of Glaukos, said in the release.